DK3016666T3 - Fiskeolieformulering omfattende reservatrol eller derivater deraf til anvendelse ved behandling, forsinkelse og/eller forebyggelse af Alzheimers sygdom - Google Patents

Fiskeolieformulering omfattende reservatrol eller derivater deraf til anvendelse ved behandling, forsinkelse og/eller forebyggelse af Alzheimers sygdom Download PDF

Info

Publication number
DK3016666T3
DK3016666T3 DK14811285.7T DK14811285T DK3016666T3 DK 3016666 T3 DK3016666 T3 DK 3016666T3 DK 14811285 T DK14811285 T DK 14811285T DK 3016666 T3 DK3016666 T3 DK 3016666T3
Authority
DK
Denmark
Prior art keywords
reservatrol
delaying
disease
derivatives
treating
Prior art date
Application number
DK14811285.7T
Other languages
English (en)
Inventor
Janne Sande Mathisen
Henrik Mathisen
Original Assignee
Smartfish As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52022528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3016666(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smartfish As filed Critical Smartfish As
Application granted granted Critical
Publication of DK3016666T3 publication Critical patent/DK3016666T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK14811285.7T 2013-06-13 2014-06-13 Fiskeolieformulering omfattende reservatrol eller derivater deraf til anvendelse ved behandling, forsinkelse og/eller forebyggelse af Alzheimers sygdom DK3016666T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361834455P 2013-06-13 2013-06-13
PCT/NO2014/050099 WO2014200356A1 (en) 2013-06-13 2014-06-13 A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease

Publications (1)

Publication Number Publication Date
DK3016666T3 true DK3016666T3 (da) 2019-07-01

Family

ID=52022528

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14811285.7T DK3016666T3 (da) 2013-06-13 2014-06-13 Fiskeolieformulering omfattende reservatrol eller derivater deraf til anvendelse ved behandling, forsinkelse og/eller forebyggelse af Alzheimers sygdom

Country Status (15)

Country Link
US (1) US9717704B2 (da)
EP (1) EP3016666B1 (da)
JP (2) JP6648007B2 (da)
KR (1) KR20160018801A (da)
CN (1) CN105283190A (da)
AU (1) AU2014278839B2 (da)
CA (1) CA2914767A1 (da)
DK (1) DK3016666T3 (da)
ES (1) ES2732307T3 (da)
HK (1) HK1223263A1 (da)
MX (1) MX363853B (da)
PL (1) PL3016666T3 (da)
PT (1) PT3016666T (da)
SI (1) SI3016666T1 (da)
WO (1) WO2014200356A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2907853A1 (en) 2013-04-19 2014-10-23 The Board Of Trustees Of The University Of Arkansas Combretastatin analogs
WO2014210036A1 (en) 2013-06-24 2014-12-31 Wilson Wolf Manufacturing Corporation Closed system device and methods for gas permeable cell culture process
GB201405033D0 (en) 2014-03-20 2014-05-07 Isis Innovation Combination therapy
WO2015153635A1 (en) 2014-03-31 2015-10-08 Board Of Trustees Of The University Of Arkansas Disubstituted triazole analogs
NO20160913A1 (en) * 2016-05-27 2017-11-28 Smartfish As Use of a composition comprising marine oil and juice for improving muscle performance.
US20200024249A1 (en) * 2017-02-02 2020-01-23 Bioventures, Llc Methods of protecting against neurodegeneration

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897388A (en) * 1988-12-20 1990-01-30 Geriatric Research Institute, Inc. Method of treating Alzheimer's disease
US6184248B1 (en) 1996-09-05 2001-02-06 Robert K. K. Lee Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
NO313076B1 (no) * 1999-12-28 2002-08-12 Pronova Biocare As Flytende n¶rings- og/eller nytelsesmiddel og fremgangsmåte for fremstilling derav
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
WO2004105517A1 (en) * 2003-05-27 2004-12-09 Dsm Ip Assets B.V. Novel nutraceutical compositions and use thereof
NO322041B1 (no) 2004-10-22 2006-08-07 Pharmalogica As Naeringsmiddelsupplement inneholdende fiskeolje og melkefaststoff som emulgator og fremgangsmate for fremstilling.
US20060172012A1 (en) * 2005-01-28 2006-08-03 Finley John W Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks
NO323665B1 (no) 2005-06-27 2007-06-18 Pharmalogica As Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling.
NO324262B1 (no) 2005-11-29 2007-09-17 Pharmalogica As Bruksklar sammensetning omfattende fiskeolje og juice og fremstilling av denne, samt en forseglet beholder.
US20080058418A1 (en) * 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
DE202007013532U1 (de) * 2007-09-26 2007-12-13 Orthomol Pharmazeutische Vertriebs Gmbh Zusammensetzung enthaltende Phospholipide, geeignet zur Stärkung der Gehirn- und Gedächtnisfunktion
NO20081487L (no) 2008-03-27 2009-09-28 Smartfish As Helsefremmende drikk
NO333013B1 (no) * 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
EP2279667A1 (en) * 2009-07-30 2011-02-02 Brudy Technology, S.L. Vegetable and marine oil or fat compositions enriched with DHA or EPA and C18 or higher fatty acid
WO2012025229A1 (en) * 2010-08-27 2012-03-01 Persavita Ltd. Composition and method of manufacture
EP2685987B1 (en) * 2011-03-18 2019-04-24 Nestec S.A. Compositions and methods useful for ameliorating age related maladies
WO2014000264A1 (en) 2012-06-29 2014-01-03 Qualcomm Incorporated Td-scdma rscp measurement correlation

Also Published As

Publication number Publication date
HK1223263A1 (zh) 2017-07-28
JP2019081807A (ja) 2019-05-30
SI3016666T1 (sl) 2019-09-30
ES2732307T3 (es) 2019-11-21
MX363853B (es) 2019-04-05
JP6648007B2 (ja) 2020-02-14
AU2014278839B2 (en) 2019-06-20
US20150031653A1 (en) 2015-01-29
EP3016666B1 (en) 2019-05-15
WO2014200356A1 (en) 2014-12-18
PT3016666T (pt) 2019-07-11
EP3016666A4 (en) 2017-03-15
PL3016666T3 (pl) 2019-09-30
EP3016666A1 (en) 2016-05-11
AU2014278839A1 (en) 2015-12-10
JP2016523857A (ja) 2016-08-12
CN105283190A (zh) 2016-01-27
KR20160018801A (ko) 2016-02-17
CA2914767A1 (en) 2014-12-18
MX2015016931A (es) 2016-04-04
US9717704B2 (en) 2017-08-01

Similar Documents

Publication Publication Date Title
DK3258942T3 (da) Kosmetiske og topiske sammensætninger omfattende cannabigerol og cannabidiol
SI3129355T1 (sl) Fungicidni derivati N'-(2-metil-6-(2-alkoksi-etoksi)-3-piridil)-N-alkil-formamida za uporabo v poljedelstvu
CL2015002221A1 (es) Método para convertir insectos o gusanos en flujos de nutrientes y las composiciones obtenidas de ese modo.
DK3492455T3 (da) 1,2,4-triazoler som nukleare transportmodulatorer og anvendelse til behandling af specifikke former for cancer
BR112015031475A2 (pt) composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto.
BR112015003397A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente.
DK3004110T3 (da) Pyrazolpyrrolidin-derivater og disses anvendelse ved behandlingen af sygdom
DK3016666T3 (da) Fiskeolieformulering omfattende reservatrol eller derivater deraf til anvendelse ved behandling, forsinkelse og/eller forebyggelse af Alzheimers sygdom
BR112015003332A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
BR112015003398A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
FR3003566B1 (fr) Composition comprenant hf et e-3,3,3-trifluoro-1-chloropropene
DK3010506T3 (da) Pridopidin i behandling af huntingtons sygdom
DK3081568T3 (da) Sammensætninger og fremgangsmåder til behandling af alzheimers sygdom
DK3395353T3 (da) Plasminogen til anvendelse til behandling eller forebyggelse af diabetes-mellitus-nerveskade
CL2014002348A1 (es) Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado.
DK3149015T3 (da) Minimale saponin-analoger, syntese og anvendelse deraf
SG11201508730TA (en) Dna-binding protein using ppr motif, and use thereof
DK3119911T3 (da) Forbindelser til anvendelse til behandling af alzheimers sygdom hos apoe4+/+ patienter
DK3268374T3 (da) Kv1.3-inhibitorer og deres medicinske anvendelse
BR112014031512A2 (pt) composição cosmética e método para o tratamento cosmético.
DK3019129T3 (da) Øjenmaske til bedring eller forebyggelse af tørre øjne og lignende
DK3086784T3 (da) Bicalutamid analoger eller (s)-bicalutamid som exocytose aktiverende forbindelser til brug i behandling af lysosomal lagringssygdom eller glycogenose
MA45848A (fr) Cobicistat destiné à être utilisé dans des traitements du cancer
DK3383872T3 (da) 1,3,4-thiadiazolforbindelser og anvendelse deraf i cancerbehandling
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme